mAb Process Development and Optimization

31. IND Prep Versus Clinical/Commercial Scale-Up In Novel Protein Therapeutics 9/13/2024

    In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, panelists share detailed considerations for scale-up of complex protein therapeutics.

32. What Analytics Drive Process Intensification? 8/27/2024

    Bioprocess Online Live panelists discuss the most fundamental analytics that inform and enable process intensification strategies in this segment of Bioprocess Intensification In The Real World.

33. A Robust, Future-Ready Solution That Adapts To Your Needs 5/22/2025

    Explore a future-ready solution that features advanced automation, intuitive design, and scalable solutions to streamline your bioprocessing workflows and prepare your operations for future growth.

34. Fast Track Your Path To Commercialization 5/21/2025

    Discover key strategies for scaling biologics from bench to pilot scale and learn how to overcome challenges in process development, including control of agitation, oxygen, CO₂, and nutrient supplementation.

35. Development Of A CHO Medium And Feed System Using Advanced Analytical Tools And Workflow Considerations 6/16/2025

    Discover how multiomics analysis and optimized formulations in a new cell culture medium deliver higher protein titers and specific productivity for CHO fed-batch systems.

36. Process Intensification Development Challenges At AZ and AbbVie 8/27/2024

    In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, panelists respond to audience questions about the challenges they’ve encountered while developing process intensification strategies.

37. Accelerating mAb Process Development In The Growing Therapeutics Market 8/20/2024

    The market for mAbs and mAb variants is growing rapidly. Explore the latest strategies and advancements in early stage mAb up- and downstream process development.

38. Nunc Standard Closed Cell Factory System 2/2/2022

    This clean and closed system is designed to provide consistent and high-quality results to enhance your adherent cell culture processes. This ready-to-use system will help you quickly develop and scale up your processes with standard components for supply assurance.

39. Upstream To Downstream: A Comprehensive Approach To AAV Production 12/7/2023

    How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.

40. Advances In Custom Medium Development: The Multi-Omics Difference 6/9/2025

    Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.